| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052881361 |
| P356 | DOI | 10.1186/S40169-016-0125-2 |
| P932 | PMC publication ID | 5130937 |
| P698 | PubMed publication ID | 27905089 |
| P50 | author | Caroline Quach-Thanh | Q56986030 |
| P2093 | author name string | Marek Malecki | |
| Xenia Tombokan | |||
| Emily Putzer | |||
| Chaitanya Dodivenaka | |||
| P2860 | cites work | Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains | Q24531284 |
| Cancer immunotherapy: moving beyond current vaccines | Q24548229 | ||
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
| Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes | Q33815041 | ||
| Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels | Q34493886 | ||
| Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification | Q35198222 | ||
| Shedding light on immunotherapy for cancer | Q35740689 | ||
| Treatment of HER2-positive breast cancer. | Q35740877 | ||
| Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen | Q41752031 | ||
| Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 | ||
| Peroxisome remnants in pex3delta cells and the requirement of Pex3p for interactions between the peroxisomal docking and translocation subcomplexes | Q46546589 | ||
| Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and sequencing. | Q54334800 | ||
| Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients | Q67524223 | ||
| Enzyme coupled immunoassay of insulin using a novel coupling reagent | Q67757757 | ||
| Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer | Q68090336 | ||
| Overexpression of HER-2 in ovarian carcinomas | Q73715134 | ||
| Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination | Q74092600 | ||
| Ten-year relative survival for epithelial ovarian cancer | Q84852379 | ||
| P433 | issue | 1 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| ovarian cancer | Q172341 | ||
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 44 | |
| P577 | publication date | 2016-11-30 | |
| P1433 | published in | Clinical and translational medicine | Q27724586 |
| P1476 | title | Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus | |
| P478 | volume | 5 |
| Q48194503 | Immunotherapy as an Option for Cancer Treatment. | cites work | P2860 |
Search more.